Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy
Recruiting now
Conditions studied: Head and Neck Cancer
In brief
The primary and general objective of the clinical introduction of the Standard Follow-up Program (SFP) as the current standard of care is to improve the quality of radiotherapy for head and neck cancer patients by reducing radiation-induced side effects without hampering treatment efficacy in terms of locoregional tumour control and overall survival and to systematically evaluate the beneficial effect of newly introduced radiation technology for this particular group of patients. The clinical introduction of the SFP will allow for a systematic and broad scale quality improvement cycle for head and neck cancer patients treated with radiotherapy. In fact, this methodology can be considered a kind of quality circle for the clinical introduction of new radiation techniques, aiming at continuous efforts for further improvement.
Key facts
- Study ID
- NCT01985984
- Run by
- Maastricht Radiation Oncology
- People needed
- 1000
- Starts
- 2012-07-01
- Expected to finish
- 2030-01-01
- Last updated by the study team
- 2025-08-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients planned for curatively intended primary or postoperative radiotherapy
You may not qualify if…
- All patients planned for palliative radiotherapy
Where it is running
- Maastro Clinic — Maastricht, Netherlands (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.